SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5cad'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2HRE_B_CHDB701_0 (FERROCHELATASE)	5cad	SM80.1 VICILIN (Solanum melongena)	3 / 3	LYS A 89 GLY A 210 PRO A 211	None	0.99A	2hreB-5cadA: undetectable	2hreB-5cadA: 21.25
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3EL0_A_1UNA201_1 (PROTEASE)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 8	GLY A 338 ALA A 244 ASP A 243 ILE A 72	None	0.64A	3el0A-5cadA: undetectable	3el0A-5cadA: 11.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_C_MTXC164_1 (DIHYDROFOLATE REDUCTASE)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	LEU A 101 PHE A 73 SER A 107 ILE A 109 LEU A 111	None PCA A 403 ( 4.8A) None None None	1.15A	3ia4C-5cadA: undetectable	3ia4C-5cadA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_D_MTXD164_1 (DIHYDROFOLATE REDUCTASE)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	LEU A 101 PHE A 73 SER A 107 ILE A 109 LEU A 111	None PCA A 403 ( 4.8A) None None None	1.19A	3ia4D-5cadA: undetectable	3ia4D-5cadA: 17.22
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3J7Z_A_ERYA9000_0 (23S RRNA 50S RIBOSOMAL PROTEIN L22 ERMCL NASCENT CHAIN)	5cad	SM80.1 VICILIN (Solanum melongena)	3 / 3	LYS A 97 ILE A 251 PHE A 225	None	0.91A	3j7zS-5cadA: undetectable 3j7za-5cadA: undetectable	3j7zS-5cadA: 15.62 3j7za-5cadA: 4.91
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N3I_A_ROCA201_1 (PROTEASE)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	GLY A 338 ALA A 244 ASP A 243 VAL A 100 ALA A 247	None None None None ACT A 402 ( 3.8A)	0.96A	3n3iA-5cadA: undetectable	3n3iA-5cadA: 19.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OF4_B_ACTB313_0 (NITROREDUCTASE)	5cad	SM80.1 VICILIN (Solanum melongena)	3 / 3	ALA A 389 VAL A 388 GLN A 382	None	0.66A	3of4B-5cadA: undetectable	3of4B-5cadA: 22.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3SUD_B_SUEB1201_1 (NS3 PROTEASE, NS4A PROTEIN)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	ILE A 72 GLY A 336 ALA A 247 PHE A 248 ALA A 231	None None ACT A 402 ( 3.8A) None None	1.02A	3sudB-5cadA: undetectable	3sudB-5cadA: 18.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1G_A_LNLA701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	PHE A 162 ILE A 169 PHE A 173 TYR A 150 GLY A 142	None	1.02A	4e1gA-5cadA: undetectable	4e1gA-5cadA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4E1G_B_LNLB701_1 (PROSTAGLANDIN G/H SYNTHASE 2)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	PHE A 162 ILE A 169 PHE A 173 TYR A 150 GLY A 142	None	1.05A	4e1gB-5cadA: undetectable	4e1gB-5cadA: 20.23
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4F3T_A_IPHA901_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 4	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.29A	4f3tA-5cadA: undetectable	4f3tA-5cadA: 18.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4NKX_B_STRB601_2 (STEROID 17-ALPHA-HYDROXYLASE /17,20 LYASE)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 5	ILE A 72 LEU A 125 ASP A 243 GLU A 70	None	1.04A	4nkxB-5cadA: undetectable	4nkxB-5cadA: 21.40
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RP8_C_ASCC501_0 (ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	ILE A 109 HIS A 65 ILE A 54 PHE A 30 MET A 62	None PCA A 403 (-3.9A) None PCA A 403 (-4.1A) PCA A 403 ( 4.9A)	1.05A	4rp8C-5cadA: undetectable	4rp8C-5cadA: 21.52
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5O_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 5	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.27A	4w5oA-5cadA: undetectable	4w5oA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5R_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 4	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.27A	4w5rA-5cadA: undetectable	4w5rA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4W5T_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 4	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.29A	4w5tA-5cadA: undetectable	4w5tA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4C_A_IPHA905_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 5	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.28A	4z4cA-5cadA: undetectable	4z4cA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4D_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 5	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.28A	4z4dA-5cadA: undetectable	4z4dA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4E_A_IPHA906_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 5	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.26A	4z4eA-5cadA: undetectable	4z4eA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4Z4G_A_IPHA904_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 4	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.30A	4z4gA-5cadA: undetectable	4z4gA-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZJ8_A_SUVA2001_2 (HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 6	ILE A 72 HIS A 65 ILE A 84 VAL A 208	None PCA A 403 (-3.9A) None None	0.79A	4zj8A-5cadA: undetectable	4zj8A-5cadA: 19.10
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CAD_A_ACTA402_0 (SM80.1 VICILIN)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 6	PHE A 228 ALA A 247 ASN A 344 ARG A 267	ACT A 402 (-4.8A) ACT A 402 ( 3.8A) None ACT A 402 (-3.9A)	1.23A	5cadA-5cadA: 62.9	5cadA-5cadA: 100.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	5CAD_A_ACTA402_0 (SM80.1 VICILIN)	5cad	SM80.1 VICILIN (Solanum melongena)	6 / 6	PHE A 228 ALA A 247 TYR A 260 ASN A 262 ARG A 267 LYS A 346	ACT A 402 (-4.8A) ACT A 402 ( 3.8A) ACT A 402 (-4.5A) ACT A 402 (-3.3A) ACT A 402 (-3.9A) ACT A 402 (-2.9A)	0.00A	5cadA-5cadA: 62.9	5cadA-5cadA: 100.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5I8F_A_ML1A210_1 (PHENOLIC OXIDATIVE COUPLING PROTEIN)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 12	LEU A 33 VAL A 53 PHE A 19 VAL A 271 GLY A 336	None	1.44A	5i8fA-5cadA: undetectable	5i8fA-5cadA: 17.85
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5KI6_A_IPHA902_0 (PROTEIN ARGONAUTE-2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 4	PHE A 337 VAL A 51 ALA A 270 PHE A 19	None	1.28A	5ki6A-5cadA: undetectable	5ki6A-5cadA: 18.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O4Y_A_CCSA14_0 (PHE-MAA-ASN-PRO-HIS- LEU-SER-TRP-SER-TRP- 9KK-9KK-ARG-CCS-GLY- NH2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 6	LEU A 349 TRP A 356 ARG A 357 GLY A 351	None	1.10A	5o4yA-5cadA: undetectable	5o4yA-5cadA: 3.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5O4Y_F_CCSF14_0 (PHE-MAA-ASN-PRO-HIS- LEU-SER-TRP-SER-TRP- 9KK-9KK-ARG-CCS-GLY- NH2)	5cad	SM80.1 VICILIN (Solanum melongena)	4 / 6	LEU A 349 TRP A 356 ARG A 357 GLY A 351	None	1.02A	5o4yF-5cadA: undetectable	5o4yF-5cadA: 3.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJS_A_SALA603_0 (VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2)	5cad	SM80.1 VICILIN (Solanum melongena)	7 / 11	GLY A 336 MET A 249 TYR A 260 ASN A 262 ARG A 267 PHE A 324 LYS A 346	None None ACT A 402 (-4.5A) ACT A 402 (-3.3A) ACT A 402 (-3.9A) None ACT A 402 (-2.9A)	1.20A	5yjsA-5cadA: 51.0	5yjsA-5cadA: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJS_A_SALA603_0 (VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2)	5cad	SM80.1 VICILIN (Solanum melongena)	9 / 11	PHE A 228 MET A 249 TYR A 260 ASN A 262 ARG A 267 VAL A 269 PHE A 324 GLY A 336 LYS A 346	ACT A 402 (-4.8A) None ACT A 402 (-4.5A) ACT A 402 (-3.3A) ACT A 402 (-3.9A) None None None ACT A 402 (-2.9A)	0.31A	5yjsA-5cadA: 51.0	5yjsA-5cadA: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJS_A_SALA603_0 (VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 11	PHE A 228 TYR A 260 VAL A 334 PHE A 324 LYS A 346	ACT A 402 (-4.8A) ACT A 402 (-4.5A) None None ACT A 402 (-2.9A)	1.50A	5yjsA-5cadA: 51.0	5yjsA-5cadA: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJS_B_SALB601_0 (VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2)	5cad	SM80.1 VICILIN (Solanum melongena)	9 / 9	PHE A 228 MET A 249 TYR A 260 ASN A 262 ARG A 267 VAL A 269 PHE A 324 GLY A 336 LYS A 346	ACT A 402 (-4.8A) None ACT A 402 (-4.5A) ACT A 402 (-3.3A) ACT A 402 (-3.9A) None None None ACT A 402 (-2.9A)	0.34A	5yjsB-5cadA: 51.0	5yjsB-5cadA: 13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YJS_B_SALB601_0 (VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2)	5cad	SM80.1 VICILIN (Solanum melongena)	5 / 9	PHE A 228 TYR A 260 VAL A 334 PHE A 324 LYS A 346	ACT A 402 (-4.8A) ACT A 402 (-4.5A) None None ACT A 402 (-2.9A)	1.49A	5yjsB-5cadA: 51.0	5yjsB-5cadA: 13.54

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["2HRE_B_CHDB701_0","FERROCHELATASE","5cad","SM80.1 VICILIN","Solanum melongena",3,"LYS A  89;GLY A 210;PRO A 211","None","0.99A","2hreB-5cadA:undetectable","2hreB-5cadA:21.25"],["3EL0_A_1UNA201_1","PROTEASE","5cad","SM80.1 VICILIN","Solanum melongena",4,"GLY A 338;ALA A 244;ASP A 243;ILE A  72","None","0.64A","3el0A-5cadA:undetectable","3el0A-5cadA:11.31"],["3IA4_C_MTXC164_1","DIHYDROFOLATE REDUCTASE","5cad","SM80.1 VICILIN","Solanum melongena",5,"LEU A 101;PHE A  73;SER A 107;ILE A 109;LEU A 111","None;PCA A 403 ( 4.8A);None;None;None","1.15A","3ia4C-5cadA:undetectable","3ia4C-5cadA:17.22"],["3IA4_D_MTXD164_1","DIHYDROFOLATE REDUCTASE","5cad","SM80.1 VICILIN","Solanum melongena",5,"LEU A 101;PHE A  73;SER A 107;ILE A 109;LEU A 111","None;PCA A 403 ( 4.8A);None;None;None","1.19A","3ia4D-5cadA:undetectable","3ia4D-5cadA:17.22"],["3J7Z_A_ERYA9000_0","23S RRNA;50S RIBOSOMAL PROTEIN L22;ERMCL NASCENT CHAIN","5cad","SM80.1 VICILIN","Solanum melongena",3,"LYS A  97;ILE A 251;PHE A 225","None","0.91A","3j7zS-5cadA:undetectable;3j7za-5cadA:undetectable","3j7zS-5cadA:15.62;3j7za-5cadA:4.91"],["3N3I_A_ROCA201_1","PROTEASE","5cad","SM80.1 VICILIN","Solanum melongena",5,"GLY A 338;ALA A 244;ASP A 243;VAL A 100;ALA A 247","None;None;None;None;ACT A 402 ( 3.8A)","0.96A","3n3iA-5cadA:undetectable","3n3iA-5cadA:19.57"],["3OF4_B_ACTB313_0","NITROREDUCTASE","5cad","SM80.1 VICILIN","Solanum melongena",3,"ALA A 389;VAL A 388;GLN A 382","None","0.66A","3of4B-5cadA:undetectable","3of4B-5cadA:22.47"],["3SUD_B_SUEB1201_1","NS3 PROTEASE, NS4A PROTEIN","5cad","SM80.1 VICILIN","Solanum melongena",5,"ILE A  72;GLY A 336;ALA A 247;PHE A 248;ALA A 231","None;None;ACT A 402 ( 3.8A);None;None","1.02A","3sudB-5cadA:undetectable","3sudB-5cadA:18.58"],["4E1G_A_LNLA701_1","PROSTAGLANDIN G\/H SYNTHASE 2","5cad","SM80.1 VICILIN","Solanum melongena",5,"PHE A 162;ILE A 169;PHE A 173;TYR A 150;GLY A 142","None","1.02A","4e1gA-5cadA:undetectable","4e1gA-5cadA:20.23"],["4E1G_B_LNLB701_1","PROSTAGLANDIN G\/H SYNTHASE 2","5cad","SM80.1 VICILIN","Solanum melongena",5,"PHE A 162;ILE A 169;PHE A 173;TYR A 150;GLY A 142","None","1.05A","4e1gB-5cadA:undetectable","4e1gB-5cadA:20.23"],["4F3T_A_IPHA901_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.29A","4f3tA-5cadA:undetectable","4f3tA-5cadA:18.65"],["4NKX_B_STRB601_2","STEROID 17-ALPHA-HYDROXYLASE\/17,20 LYASE","5cad","SM80.1 VICILIN","Solanum melongena",4,"ILE A  72;LEU A 125;ASP A 243;GLU A  70","None","1.04A","4nkxB-5cadA:undetectable","4nkxB-5cadA:21.40"],["4RP8_C_ASCC501_0","ASCORBATE-SPECIFIC PERMEASE IIC COMPONENT ULAA","5cad","SM80.1 VICILIN","Solanum melongena",5,"ILE A 109;HIS A  65;ILE A  54;PHE A  30;MET A  62","None;PCA A 403 (-3.9A);None;PCA A 403 (-4.1A);PCA A 403 ( 4.9A)","1.05A","4rp8C-5cadA:undetectable","4rp8C-5cadA:21.52"],["4W5O_A_IPHA906_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.27A","4w5oA-5cadA:undetectable","4w5oA-5cadA:18.07"],["4W5R_A_IPHA904_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.27A","4w5rA-5cadA:undetectable","4w5rA-5cadA:18.07"],["4W5T_A_IPHA904_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.29A","4w5tA-5cadA:undetectable","4w5tA-5cadA:18.07"],["4Z4C_A_IPHA905_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.28A","4z4cA-5cadA:undetectable","4z4cA-5cadA:18.07"],["4Z4D_A_IPHA904_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.28A","4z4dA-5cadA:undetectable","4z4dA-5cadA:18.07"],["4Z4E_A_IPHA906_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.26A","4z4eA-5cadA:undetectable","4z4eA-5cadA:18.07"],["4Z4G_A_IPHA904_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.30A","4z4gA-5cadA:undetectable","4z4gA-5cadA:18.07"],["4ZJ8_A_SUVA2001_2","HUMAN OX1R FUSION PROTEIN TO P.ABYSII GLYCOGEN SYNTHASE","5cad","SM80.1 VICILIN","Solanum melongena",4,"ILE A  72;HIS A  65;ILE A  84;VAL A 208","None;PCA A 403 (-3.9A);None;None","0.79A","4zj8A-5cadA:undetectable","4zj8A-5cadA:19.10"],["5CAD_A_ACTA402_0","SM80.1 VICILIN","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 228;ALA A 247;ASN A 344;ARG A 267","ACT A 402 (-4.8A);ACT A 402 ( 3.8A);None;ACT A 402 (-3.9A)","1.23A","5cadA-5cadA:62.9","5cadA-5cadA:100.00"],["5CAD_A_ACTA402_0","SM80.1 VICILIN","5cad","SM80.1 VICILIN","Solanum melongena",6,"PHE A 228;ALA A 247;TYR A 260;ASN A 262;ARG A 267;LYS A 346","ACT A 402 (-4.8A);ACT A 402 ( 3.8A);ACT A 402 (-4.5A);ACT A 402 (-3.3A);ACT A 402 (-3.9A);ACT A 402 (-2.9A)","0.00A","5cadA-5cadA:62.9","5cadA-5cadA:100.00"],["5I8F_A_ML1A210_1","PHENOLIC OXIDATIVE COUPLING PROTEIN","5cad","SM80.1 VICILIN","Solanum melongena",5,"LEU A  33;VAL A  53;PHE A  19;VAL A 271;GLY A 336","None","1.44A","5i8fA-5cadA:undetectable","5i8fA-5cadA:17.85"],["5KI6_A_IPHA902_0","PROTEIN ARGONAUTE-2","5cad","SM80.1 VICILIN","Solanum melongena",4,"PHE A 337;VAL A  51;ALA A 270;PHE A  19","None","1.28A","5ki6A-5cadA:undetectable","5ki6A-5cadA:18.07"],["5O4Y_A_CCSA14_0","PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2","5cad","SM80.1 VICILIN","Solanum melongena",4,"LEU A 349;TRP A 356;ARG A 357;GLY A 351","None","1.10A","5o4yA-5cadA:undetectable","5o4yA-5cadA:3.19"],["5O4Y_F_CCSF14_0","PHE-MAA-ASN-PRO-HIS-LEU-SER-TRP-SER-TRP-9KK-9KK-ARG-CCS-GLY-NH2","5cad","SM80.1 VICILIN","Solanum melongena",4,"LEU A 349;TRP A 356;ARG A 357;GLY A 351","None","1.02A","5o4yF-5cadA:undetectable","5o4yF-5cadA:3.19"],["5YJS_A_SALA603_0","VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2","5cad","SM80.1 VICILIN","Solanum melongena",7,"GLY A 336;MET A 249;TYR A 260;ASN A 262;ARG A 267;PHE A 324;LYS A 346","None;None;ACT A 402 (-4.5A);ACT A 402 (-3.3A);ACT A 402 (-3.9A);None;ACT A 402 (-2.9A)","1.20A","5yjsA-5cadA:51.0","5yjsA-5cadA:13.54"],["5YJS_A_SALA603_0","VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2","5cad","SM80.1 VICILIN","Solanum melongena",9,"PHE A 228;MET A 249;TYR A 260;ASN A 262;ARG A 267;VAL A 269;PHE A 324;GLY A 336;LYS A 346","ACT A 402 (-4.8A);None;ACT A 402 (-4.5A);ACT A 402 (-3.3A);ACT A 402 (-3.9A);None;None;None;ACT A 402 (-2.9A)","0.31A","5yjsA-5cadA:51.0","5yjsA-5cadA:13.54"],["5YJS_A_SALA603_0","VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2","5cad","SM80.1 VICILIN","Solanum melongena",5,"PHE A 228;TYR A 260;VAL A 334;PHE A 324;LYS A 346","ACT A 402 (-4.8A);ACT A 402 (-4.5A);None;None;ACT A 402 (-2.9A)","1.50A","5yjsA-5cadA:51.0","5yjsA-5cadA:13.54"],["5YJS_B_SALB601_0","VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2","5cad","SM80.1 VICILIN","Solanum melongena",9,"PHE A 228;MET A 249;TYR A 260;ASN A 262;ARG A 267;VAL A 269;PHE A 324;GLY A 336;LYS A 346","ACT A 402 (-4.8A);None;ACT A 402 (-4.5A);ACT A 402 (-3.3A);ACT A 402 (-3.9A);None;None;None;ACT A 402 (-2.9A)","0.34A","5yjsB-5cadA:51.0","5yjsB-5cadA:13.54"],["5YJS_B_SALB601_0","VICILIN-LIKE ANTIMICROBIAL PEPTIDES 2-2","5cad","SM80.1 VICILIN","Solanum melongena",5,"PHE A 228;TYR A 260;VAL A 334;PHE A 324;LYS A 346","ACT A 402 (-4.8A);ACT A 402 (-4.5A);None;None;ACT A 402 (-2.9A)","1.49A","5yjsB-5cadA:51.0","5yjsB-5cadA:13.54"]]